Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,650 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,130 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,492)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00091039 | Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery | completed | N/A | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00635791 | Phase I Study of Vorinostat and Sorafenib in Advanced Cancer | completed | Phase 1 | 36 | University of Colorado, DenverOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00871403 | Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 107 | GlaxoSmithKlineINDUSTRY | 2 | Jun 20, 2013 | clinicaltrials |
| NCT00004238 | 10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00004249 | Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00004930 | Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00005630 | Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00005806 | Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00452634 | Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC) | completed | Phase 2 | 62 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00620347 | Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer | completed | Phase 2 | 25 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00027638 | Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00433602 | Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors | completed | — | 64 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jun 12, 2013 | clinicaltrials |
| NCT00536640 | Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab(INNOVATIONS) | completed | Phase 2 | 224 | Aktion Bronchialkarzinom e.V.OTHER | 1 | Jun 12, 2013 | clinicaltrials |
| NCT00062101 | Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00040794 | Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer | completed | Phase 2 | 144 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00081107 | Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00005065 | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | completed | Phase 1 | 12 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00006929 | Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | completed | Phase 2 | 82 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00028535 | Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00055757 | Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00066768 | Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00118183 | Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 62 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00927875 | A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer | completed | Phase 1 | 5 | Bristol-Myers SquibbINDUSTRY | 5 | Jun 3, 2013 | clinicaltrials |
| NCT00104793 | Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 55 | Japan Multinational Trial OrganizationOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00132054 | Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer | completed | Phase 1 | 30 | Japan Multinational Trial OrganizationOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00659568 | Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma | completed | Phase 1 | 28 | London Health Sciences CentreOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00662324 | Development of a Clinical Trial Specific Question Prompt List | completed | — | 67 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT01079481 | Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer | completed | Phase 1 | 21 | Samsung Medical CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT01125995 | Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer | completed | Phase 3 | 222 | Samsung Medical CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00601796 | Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer | completed | Phase 2 | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 24, 2013 | clinicaltrials |
| NCT00653250 | Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer | completed | N/A | 22 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | May 21, 2013 | clinicaltrials |
| NCT00855894 | A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer(PENGUIN) | completed | Phase 2 | 41 | Genentech, Inc.INDUSTRY | 2 | May 21, 2013 | clinicaltrials |
| NCT00004176 | Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | completed | Phase 2 | 34 | Washington University School of MedicineOTHER | 1 | May 16, 2013 | clinicaltrials |
| NCT00002470 | Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors | completed | Phase 2 | — | Mid-Atlantic Oncology ProgramOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00021138 | Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop Smoking | completed | N/A | — | Personal Improvement Computer SystemsOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00077415 | 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 31 | Cancer Therapeutics Research GroupOTHER | 4 | May 15, 2013 | clinicaltrials |
| NCT00050973 | Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer | completed | Phase 3 | 623 | Eisai Inc.INDUSTRY | 11 | May 14, 2013 | clinicaltrials |
| NCT00411047 | Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 34 | Massachusetts General HospitalOTHER | 1 | May 14, 2013 | clinicaltrials |
| NCT00117442 | A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood | completed | Phase 2 | 61 | AmgenINDUSTRY | 0 | May 13, 2013 | clinicaltrials |
| NCT01141842 | Early Detection of Lung Tumors by Sniffer Dogs - Evaluation of Sensitivity and Specificity | completed | Phase 1 | 230 | Schillerhoehe HospitalOTHER | 1 | May 7, 2013 | clinicaltrials |
| NCT00293280 | Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 42 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | May 6, 2013 | clinicaltrials |
| NCT00425646 | Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 50 | University of WashingtonOTHER | 1 | May 6, 2013 | clinicaltrials |
| NCT00002519 | Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer | completed | Phase 1 | 6 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 3, 2013 | clinicaltrials |
| NCT00006368 | Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer | completed | Phase 1 | 60 | Novartis PharmaceuticalsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT00006370 | Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer | completed | Phase 2 | 275 | Novartis PharmaceuticalsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT00404365 | Depression Screening in Patients With Lung Cancer | completed | N/A | 241 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 1, 2013 | clinicaltrials |
| NCT00002656 | Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 20 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 29, 2013 | clinicaltrials |
| NCT00030407 | Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 34 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 29, 2013 | clinicaltrials |
| NCT00030420 | Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 24 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 29, 2013 | clinicaltrials |
| NCT00056004 | Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia | completed | Phase 2 | 38 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 29, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Jun 20, 2013source: clinicaltrials